- Home
- MIRM vs BKE Comparison
MIRM vs BKE Comparison
Compare MIRM & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRM
- BKE
- Stock Information
- Founded
- MIRM 2018
- BKE 1948
- Country
- MIRM United States
- BKE United States
- Employees
- MIRM N/A
- BKE N/A
- Industry
- MIRM Biotechnology: Pharmaceutical Preparations
- BKE Clothing/Shoe/Accessory Stores
- Sector
- MIRM Health Care
- BKE Consumer Discretionary
- Exchange
- MIRM Nasdaq
- BKE Nasdaq
- Market Cap
- MIRM 3.3B
- BKE 2.9B
- IPO Year
- MIRM 2019
- BKE 1992
- Fundamental
- Price
- MIRM $76.06
- BKE $59.29
- Analyst Decision
- MIRM Strong Buy
- BKE Hold
- Analyst Count
- MIRM 9
- BKE 1
- Target Price
- MIRM $73.89
- BKE $54.00
- AVG Volume (30 Days)
- MIRM 914.8K
- BKE 589.3K
- Earning Date
- MIRM 08-06-2025
- BKE 08-22-2025
- Dividend Yield
- MIRM N/A
- BKE 6.55%
- EPS Growth
- MIRM N/A
- BKE N/A
- EPS
- MIRM N/A
- BKE 4.00
- Revenue
- MIRM $429,161,000.00
- BKE $1,250,675,000.00
- Revenue This Year
- MIRM $52.71
- BKE $3.47
- Revenue Next Year
- MIRM $19.71
- BKE $3.89
- P/E Ratio
- MIRM N/A
- BKE $14.90
- Revenue Growth
- MIRM 62.33
- BKE 1.62
- 52 Week Low
- MIRM $36.86
- BKE $33.12
- 52 Week High
- MIRM $76.40
- BKE $60.55
- Technical
- Relative Strength Index (RSI)
- MIRM 77.75
- BKE 69.18
- Support Level
- MIRM $73.12
- BKE $55.90
- Resistance Level
- MIRM $76.02
- BKE $57.83
- Average True Range (ATR)
- MIRM 2.39
- BKE 1.36
- MACD
- MIRM 0.04
- BKE 0.12
- Stochastic Oscillator
- MIRM 96.66
- BKE 82.72
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.